Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended surveys, and documents. The primary keyword for this post is qualitative analysis hyperkalaemia management, aimed at researchers and research teams who want to convert clinician interviews into reproducible, AI-enabled evidence. According to the PLOS ONE article by Gimenez-Stamminger et al., published on July 30, 2026, nephrologists in Spain followed stepwise clinical strategies to preserve RAAS inhibitor therapy while managing hyperkalaemia (PLOS ONE). This post shows how AI-enabled qualitative research can extract the study's sample statistics, thematic codes, direct quotations, and system-level barriers into actionable insights for guideline implementation and service improvement.
Key Takeaways
The PLOS ONE qualitative study by Gimenez-Stamminger et al. (published 30 July 2026) found that Spanish nephrologists use a stepwise approach to manage hyperkalaemia aimed at preserving RAAS inhibitors, but access barriers limit newer binder use (PLOS ONE).
- 12 nephrologists were interviewed in October 2025, with interviews averaging 53 minutes, according to Gimenez-Stamminger et al. in PLOS ONE (30 July 2026).
- In the PLOS ONE sample, 75% of participants had more than 15 years of clinical experience and all practised in hospital settings (Gimenez-Stamminger et al., PLOS ONE, 30 July 2026).
- The PLOS ONE study reported that newer potassium binders (patiromer and sodium zirconium cyclosilicate) were viewed as better tolerated and enabled continued RAASi use, but regional prior authorisation requirements limited timely access (Gimenez-Stamminger et al., PLOS ONE, 30 July 2026).
What Happened: study design and core findings
Answer: The PLOS ONE study used semi-structured interviews to explore nephrologists' decision-making for hyperkalaemia in predialysis CKD and produced five thematic findings about treatment, access, and patient burden.
Gimenez-Stamminger et al. recruited 12 practising nephrologists across six Spanish regions and conducted interviews in October 2025, transcribed and analysed in ATLAS.ti using a codebook-based thematic approach (PLOS ONE).
According to the PLOS ONE report, five themes emerged: a stepwise clinical algorithm prioritising RAASi preservation; newer binders as enablers; system-level access barriers (for example _visado_ prior authorisation); the central role of nursing and patient communication; and underuse of formal HRQoL measurement (Gimenez-Stamminger et al., PLOS ONE, 30 July 2026).
"I structure the management in a stepped way: first line, diet and diuretics; second line, bicarbonate or binders; third line, reduction or suspension of drugs that increase potassium, as a last resort, " said Participant ID05 in the PLOS ONE interviews (Gimenez-Stamminger et al., PLOS ONE, 30 July 2026).
"The arrival of the new binders has been a revolution. I have not had to dialyse patients urgently for hyperkalaemia for years, thanks to these treatments, " said Participant ID09, quoted in the PLOS ONE article (published 30 July 2026).
Findings Snapshot
| Date | Metric | Value | Implication |
|---|---|---|---|
| October 2025 | Interviews conducted | 12 nephrologists | Sufficient for thematic saturation in a purposive, clinician-focused qualitative study (PLOS ONE, 30 July 2026) |
| October 2025 | Average interview length | 53 minutes | Depth allowed codebook development and 30 final codes grouped into 15 subthemes (PLOS ONE, 30 July 2026) |
| Past 12 months (as of Oct 2025) | Binder prescribing experience | 50% patiromer, 50% SZC among participants | Clinicians had recent, balanced exposure to both newer binders (PLOS ONE, 30 July 2026) |
| July 30, 2026 | Publication | PLOS ONE article by Gimenez-Stamminger et al. | Peer-reviewed qualitative evidence base for clinician perspectives on the 'potassium dilemma' (PLOS ONE) |
Implications for qualitative researchers and implementation teams
Answer: The PLOS ONE findings show where qualitative evidence can inform implementation: access policy, multidisciplinary handoffs, and patient-centred outcome measurement.
Gimenez-Stamminger et al. reported clinicians perceive administrative prior authorisation (_visado_) and regional formulary variation as key barriers to timely use of newer binders, suggesting implementation research should target prescribing workflows and payer rules (PLOS ONE, 30 July 2026).
The PLOS ONE participants noted that formal HRQoL measurement was infrequent, so qualitative teams should embed patient-reported outcome instruments alongside clinician interviews to capture lived burden, as recommended in KDIGO 2024 guidelines (KDIGO 2024 Clinical Practice Guideline).
For qualitative methodologists, the PLOS ONE study demonstrates reproducible codebook development: two independent coders, iterative refinement, and an audit trail in ATLAS.ti produced 30 final codes and five themes (Gimenez-Stamminger et al., PLOS ONE, 30 July 2026).
How Evidano Helps
Problem: manual transcript coding is slow and inconsistent
Answer: Manual coding of clinician interviews creates bottlenecks in reproducibility and cross-segment analysis, as the PLOS ONE team mitigated with a team-based codebook and ATLAS.ti (Gimenez-Stamminger et al., PLOS ONE, 30 July 2026).
Solution: Evidano automates initial code suggestions, supports team codebook workflows, and exports audit trails for transparency, reducing the time from transcription to thematic synthesis.
Problem: extracting and quantifying key stats from interviews
Answer: Extracting sample statistics and code frequencies by hand limits scalability; Gimenez-Stamminger et al. reported 30 codes, 15 subthemes, and thematic saturation reached after 12 interviews (PLOS ONE, 30 July 2026).
Solution: Evidano generates frequency tables, cross-segment comparisons, and exportable snapshots to reproduce claims such as '75% of participants had >15 years experience' directly from coded transcripts.
Problem: linking qualitative themes to workflow change
Answer: Translating clinician quotes about access barriers into policy recommendations requires traceable evidence, which the PLOS ONE authors achieved with an audit trail (Gimenez-Stamminger et al., PLOS ONE, 30 July 2026).
Solution: Evidano supports evidence packages that combine verbatim quotations, code frequencies, and timeline visualizations to brief payers, hospital boards, or guideline panels, and integrates with robust transcription features such as PII redaction and custom dictionaries (Evidano features).
FAQ: qualitative analysis hyperkalaemia management
How many clinicians did the PLOS ONE study interview and does that support valid themes?
Answer: The PLOS ONE study interviewed 12 nephrologists and reported thematic saturation, which is an accepted qualitative threshold for clinician-focused research (Gimenez-Stamminger et al., PLOS ONE, 30 July 2026).
Supporting detail: The authors used purposive sampling across six Spanish regions and iterative codebook refinement, resulting in 30 final codes organised into 15 subthemes and five overarching themes, which they judged to be stable across interviews (PLOS ONE, 30 July 2026).
What concrete statistics from the study can be used in reports or presentations?
Answer: Use the study's concrete numbers: 12 participants; interviews in October 2025; average length 53 minutes; 75% had >15 years' experience; and 50% of clinicians had recent patiromer use and 50% had recent SZC use (Gimenez-Stamminger et al., PLOS ONE, 30 July 2026).
Supporting detail: The PLOS ONE manuscript also documents coding procedures and provides supporting S2 and S3 tables with code frequencies and anonymised participant characteristics for reproducibility (Gimenez-Stamminger et al., PLOS ONE, 30 July 2026).
Can AI tools reproduce the PLOS ONE codebook and quotations responsibly?
Answer: Yes, with appropriate ethical safeguards and de-identification, AI-enabled platforms can reproduce codebooks and extract anonymised quotations, but original transcripts must be handled under consent and ethics rules as the PLOS ONE authors note.
Supporting detail: Gimenez-Stamminger et al. removed identifying details and offered de-identified excerpts on request; Evidano supports PII redaction and encrypted data storage to align with such ethical requirements (Evidano data security).
Conclusion & Next Steps
The PLOS ONE qualitative study by Gimenez-Stamminger et al. (published 30 July 2026) shows that nephrologists value newer potassium binders for preserving RAASi therapy but face access and coordination barriers that qualitative research can make visible.
AI-enabled qualitative analysis accelerates reproducible synthesis of interviews, extracts the exact statistics and quotations reviewers and policy-makers need, and packages findings for implementation teams.
If you want to transform clinician interviews into audit-ready evidence and policy-ready briefings, Try Evidano for free.